The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...
Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...
Daily Caller on MSN18hOpinion
EXCLUSIVE: House Scrutinizes NIH-Funded ‘Animal Cruelty,’ Experiments On ‘Transgender Lab Rats’ As DOGE Hunts For CutsA House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...
Researchers rush to preserve federal health databases before they disappear from government websites
Journalists have long relied on federal health data for their reporting. We include several tips that they can use to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback